Shares of Inovio Pharmaceuticals dropped by a staggering 10.54% to $11.52 at 15:21 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ Composite is dropping 1.28% to $13,360.07, following last session’s downward trend, This seems, up to now, an all-around negative trend trading session today.

Inovio Pharmaceuticals’s last close was $12.88, 193.32% below its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 297.8% for the current quarter and a decline by 50.3% for the next. The company’s growth estimates for the current quarter and the next is 42.1% and 30.8%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 72.8%, now sitting on 2.11M for the twelve trailing months.

Volatility

Inovio Pharmaceuticals’s last day, last week, and last month’s average volatility was 7.45%, 6.63%, and 9.08%, respectively.

Inovio Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 8.42%, 10.11%, and 14.57%, respectively.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $11.52 at 15:21 EST, way below its 52-week high of $33.79 and way higher than its 52-week low of $3.60.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is under its 50-day moving average of $11.69 and below its 200-day moving average of $11.95.

LEAVE A REPLY

Please enter your comment!
Please enter your name here